Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex
- 15 September 2010
- journal article
- research article
- Published by Elsevier BV in Neuroscience
- Vol. 169 (4), 1651-1661
- https://doi.org/10.1016/j.neuroscience.2010.06.011
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (MH051234)
- Andrew Mellon Predoctoral Fellowship
- Scottish Rite Fellowship
This publication has 63 references indexed in Scilit:
- Synaptic Cross Talk between Perisomatic-Targeting Interneuron Classes Expressing Cholecystokinin and Parvalbumin in HippocampusJournal of Neuroscience, 2009
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in SchizophreniaArchives of General Psychiatry, 2008
- Activation of Cannabinoid-1 Receptors Disrupts Sensory Gating and Neuronal Oscillation: Relevance to SchizophreniaBiological Psychiatry, 2008
- Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates othersNeuropharmacology, 2008
- Cell type–specific gating of perisomatic inhibition by cholecystokininNature Neuroscience, 2007
- GAD67-Mediated GABA Synthesis and Signaling Regulate Inhibitory Synaptic Innervation in the Visual CortexNeuron, 2007
- Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophreniaMolecular Psychiatry, 2007
- Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmissionEuropean Journal of Neuroscience, 2007
- Molecular Composition of the Endocannabinoid System at Glutamatergic SynapsesJournal of Neuroscience, 2006
- Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cellsNature Neuroscience, 2006